RVL Pharmaceuticals plc RVLP
0.03 +0.03
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 49.72M | 17.50M | 27.76M | 240.03M | 263.70M | |
| 40.27M | 13.88M | 24.47M | 128.40M | 123.62M | |
| -58.99M | -82.75M | -90.65M | -280.69M | -98.54M | |
| -51.69M | -64.92M | -79.59M | -270.90M | -109.68M | |
| -0.58 | -0.96 | -1.31 | -5.17 | -2.42 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 44.54M | 40.44M | 114.05M | 95.86M | 70.83M | |
| 128.51M | 144.67M | 370.95M | 463.25M | 795.62M | |
| 77.42M | 67.94M | 277.09M | 348.55M | 411.78M | |
| 57.49M | 47.65M | 221.62M | 273.30M | 268.83M | |
| 51.09M | 76.73M | 93.86M | 114.71M | 383.85M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -37.81M | -54.73M | 17.59M | 33.57M | 37.56M | |
| 126.00K | 116.45M | -3.08M | -4.02M | -4.13M | |
| 41.78M | -135.33M | 3.68M | -4.69M | 3.60M | |
| 126.00K | -1.69M | -3.08M | -4.02M | -4.13M | |
| 4.10M | -73.61M | 18.19M | 24.86M | 37.03M |